RBR-5z2rr58Active, not recruitingUnknown
Evaluation of Botulinum Toxin efficacy as a therapeutic option in Male Androgenetic Alopecia
Faculdade de Ciências Médicas - Universidade do Estado do Rio de Janeiro0 sitesStarted: April 20, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20Y to 35Y (—)
- Sex
- Male
Inclusion Criteria
- •Male patients; androgenetic alopecia diagnosis; involvement of the vertex and frontotemporal recesses; age between 20 and 35 years; less than 5 years of disease evolution; all ethnicities and prototypes; patients who never used a treatment and patients who have not used medication for at least six months.
Exclusion Criteria
- •Individuals outside the age range defined for the research; evolution of disease greater than 5 years; women as this is a study aimed at a male audience. Patients with other inflammatory; patients with infectious or tumor conditions concomitant with androgenetic alopecia that affect the scalp and patients undergoing treatment for androgenetic alopecia.
Investigators
Similar Trials
Recruiting
Phase 3
Efficacy Of Botulinum Toxin In The Treatment Of AcneAcne vulgaris.Acne vulgarisL70.0IRCT20230529058336N1Tehran University of Medical Sciences30
Not yet recruiting
Phase 2
Investigating the effect of botulinum toxin on parotidectomyIRCT20210923052559N2Mashhad University of Medical Sciences100
Recruiting
Not Applicable
The Effect and safety of Botox in the treatment of patients with Spinal injury associated with Human T-cell Lymphotrofic Virus type Itropical spastic paraparesisRBR-67ynvtHospital Universitário Professor Edgard Santos
Recruiting
Phase 2
Evaluation of the effectiveness of botulinum toxin in preventing hypertrophic scarringHypertrophic scarIRCT20100314003566N15Tabriz University of Medical Sciences30
Completed
Phase 1
The effect of botulinum toxin type A on reducing salivation and quality of life in patients with cerebral palsyCerebral palsy.Cerebral palsyIRCT20220516054868N1Esfahan University of Medical Sciences30